Prednisone Completed Phase 0 Trials for Nonneoplastic Condition Treatment

IndicationsStatusPurposePhase
CompletedTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT00486421Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura